GR3004259T3 - - Google Patents

Info

Publication number
GR3004259T3
GR3004259T3 GR920400559T GR920400559T GR3004259T3 GR 3004259 T3 GR3004259 T3 GR 3004259T3 GR 920400559 T GR920400559 T GR 920400559T GR 920400559 T GR920400559 T GR 920400559T GR 3004259 T3 GR3004259 T3 GR 3004259T3
Authority
GR
Greece
Application number
GR920400559T
Other languages
Greek (el)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/947,334 external-priority patent/US4731382A/en
Application filed filed Critical
Publication of GR3004259T3 publication Critical patent/GR3004259T3/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • GPHYSICS
    • G10MUSICAL INSTRUMENTS; ACOUSTICS
    • G10HELECTROPHONIC MUSICAL INSTRUMENTS; INSTRUMENTS IN WHICH THE TONES ARE GENERATED BY ELECTROMECHANICAL MEANS OR ELECTRONIC GENERATORS, OR IN WHICH THE TONES ARE SYNTHESISED FROM A DATA STORE
    • G10H2250/00Aspects of algorithms or signal processing methods without intrinsic musical character, yet specifically adapted for or used in electrophonic musical processing
    • G10H2250/055Filters for musical processing or musical effects; Filter responses, filter architecture, filter coefficients or control parameters therefor
    • G10H2250/125Notch filters
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GR920400559T 1986-12-29 1992-04-02 GR3004259T3 (US20020128544A1-20020912-P00008.png)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/947,334 US4731382A (en) 1986-12-29 1986-12-29 Lipoxygenase inhibitory phenylalkanohydroxamic acids
US07/133,601 US4861798A (en) 1986-12-29 1987-12-22 Lipoxygenase inhibitory compounds

Publications (1)

Publication Number Publication Date
GR3004259T3 true GR3004259T3 (US20020128544A1-20020912-P00008.png) 1993-03-31

Family

ID=26831511

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920400559T GR3004259T3 (US20020128544A1-20020912-P00008.png) 1986-12-29 1992-04-02

Country Status (8)

Country Link
US (1) US4861798A (US20020128544A1-20020912-P00008.png)
EP (1) EP0273451B1 (US20020128544A1-20020912-P00008.png)
JP (1) JPS63264442A (US20020128544A1-20020912-P00008.png)
AU (1) AU614949B2 (US20020128544A1-20020912-P00008.png)
DE (1) DE3777986D1 (US20020128544A1-20020912-P00008.png)
ES (1) ES2041261T3 (US20020128544A1-20020912-P00008.png)
GR (1) GR3004259T3 (US20020128544A1-20020912-P00008.png)
NZ (1) NZ223104A (US20020128544A1-20020912-P00008.png)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02196767A (ja) * 1988-10-11 1990-08-03 Kyowa Hakko Kogyo Co Ltd ヒドロキサム酸誘導体
US5096919A (en) * 1989-01-05 1992-03-17 Ciba-Geigy Corporation Pyrrolylphenyl-substituted hydroxamic acid derivatives
US4960787A (en) * 1989-02-06 1990-10-02 Ciba-Geigy Corporation Certain pyrrolyl-substituted hydroxamic acid derivatives
JP3065636B2 (ja) * 1989-06-29 2000-07-17 塩野義製薬株式会社 [ジ―tert―ブチル(ヒドロキシ)フェニルチオ]置換ヒドロキサム酸誘導体
US5093363A (en) * 1989-08-22 1992-03-03 Shionogi & Co., Ltd. 2,4,6-substituted phenol derivatives
ATE144247T1 (de) * 1990-07-25 1996-11-15 Abbott Lab Acetylenderivate mit lipoxygenase inhibitorischer wirkung
US5476873A (en) * 1990-07-25 1995-12-19 Abbott Laboratories Acetylene derivatives having lipoxygenase inhibitory activity
US5281623A (en) * 1990-08-27 1994-01-25 Eli Lilly And Company Method for treating inflammation
GB9024820D0 (en) * 1990-11-15 1991-01-02 Davies Michael J Pharmaceutical compositions
US5280046A (en) * 1991-02-22 1994-01-18 The University Of Colorado Foundation, Inc. Method of treating type I diabetes
US5117054A (en) * 1991-09-26 1992-05-26 Ortho Pharmaceutical Corporation N-hydroxy, N-methyl propanamides
US5208364A (en) * 1992-06-25 1993-05-04 Bristol-Myers Squibb Co. Antibiotic 5-lipoxygenase inhibitors
DE69426602T2 (de) * 1993-10-19 2001-08-30 Sumitomo Pharma 2,3-diaminopropionsäurederivate
ATE154932T1 (de) * 1993-11-26 1997-07-15 Pfizer Isoxazolinverbindungen als entzündungshemmende mittel
US5804601A (en) * 1995-04-10 1998-09-08 Takeda Chemical Industries, Ltd. Aromatic hydroxamic acid compounds, their production and use
US6777217B1 (en) 1996-03-26 2004-08-17 President And Fellows Of Harvard College Histone deacetylases, and uses related thereto
US20030129724A1 (en) 2000-03-03 2003-07-10 Grozinger Christina M. Class II human histone deacetylases, and uses related thereto
JP5744376B2 (ja) 2005-03-22 2015-07-08 プレジデント アンド フェローズ オブ ハーバード カレッジ タンパク質分解障害の治療
JP5441416B2 (ja) 2006-02-14 2014-03-12 プレジデント アンド フェロウズ オブ ハーバード カレッジ 二官能性ヒストンデアセチラーゼインヒビター
WO2007130429A2 (en) * 2006-05-03 2007-11-15 The President And Fellows Of Harvard College Histone deacetylase and tubulin deacetylase inhibitors
JP5309318B2 (ja) * 2007-03-09 2013-10-09 国立大学法人 岡山大学 エステル、カルボン酸及びアミドの製造方法
KR101708946B1 (ko) 2008-07-23 2017-02-21 다나-파버 캔서 인스티튜트 인크. 탈아세틸화제 억제제 및 그것의 용도
AU2010241567B2 (en) 2009-04-29 2013-10-31 Amarin Pharmaceuticals Ireland Limited Pharmaceutical compositions comprising EPA and a cardiovascular agent and methods of using the same
WO2011019393A2 (en) 2009-08-11 2011-02-17 President And Fellows Of Harvard College Class- and isoform-specific hdac inhibitors and uses thereof
CN102526213A (zh) * 2012-01-31 2012-07-04 庞树有 治疗慢性结肠炎的中药组合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2397508A (en) * 1943-05-29 1946-04-02 Standard Oil Co Hydroxamic acids
JPS5946244A (ja) * 1982-09-09 1984-03-15 Nissan Chem Ind Ltd ヒドロキサム酸誘導体およびその製造法
JPS61118346A (ja) * 1984-11-12 1986-06-05 Yamanouchi Pharmaceut Co Ltd ω−(ジヒドロキシフエニル)アルカンカルボン酸誘導体
HU201300B (en) * 1985-03-16 1990-10-28 Wellcome Found Process for production of derivatives of aryl and medical compositions containing them as active substance
ZA862476B (en) * 1985-04-03 1986-12-30 Usv Pharma Corp Hydroxamates as modulators of arachidonic acid metabolic pathways
US4792560A (en) * 1985-04-03 1988-12-20 Rorer Pharmaceutical Corporation Quinoline hydroxamates and their use as modulators of arachidonic acid metabolic pathways
US4604407A (en) * 1985-04-04 1986-08-05 E. R. Squibb & Sons, Inc. Hydroxamates
US4731382A (en) * 1986-12-29 1988-03-15 Bristol-Myers Company Lipoxygenase inhibitory phenylalkanohydroxamic acids

Also Published As

Publication number Publication date
NZ223104A (en) 1991-05-28
AU614949B2 (en) 1991-09-19
EP0273451A2 (en) 1988-07-06
EP0273451B1 (en) 1992-04-01
EP0273451A3 (en) 1989-05-03
US4861798A (en) 1989-08-29
AU8310387A (en) 1988-06-30
JPS63264442A (ja) 1988-11-01
ES2041261T3 (es) 1993-11-16
DE3777986D1 (de) 1992-05-07

Similar Documents

Publication Publication Date Title
IN169326B (US20020128544A1-20020912-P00008.png)
US4723934B1 (US20020128544A1-20020912-P00008.png)
GR3004259T3 (US20020128544A1-20020912-P00008.png)
US4685239B1 (US20020128544A1-20020912-P00008.png)
AU7354491A (US20020128544A1-20020912-P00008.png)
DE3690749T1 (US20020128544A1-20020912-P00008.png)
DE3790032T1 (US20020128544A1-20020912-P00008.png)
AU6562586A (US20020128544A1-20020912-P00008.png)
IN167616B (US20020128544A1-20020912-P00008.png)
AU7131791A (US20020128544A1-20020912-P00008.png)
IN170124B (US20020128544A1-20020912-P00008.png)
AU5614386A (US20020128544A1-20020912-P00008.png)
AU5703286A (US20020128544A1-20020912-P00008.png)
IN167221B (US20020128544A1-20020912-P00008.png)
IN167119B (US20020128544A1-20020912-P00008.png)
IN167044B (US20020128544A1-20020912-P00008.png)
IN164893B (US20020128544A1-20020912-P00008.png)
AU4375585A (US20020128544A1-20020912-P00008.png)
AU4596985A (US20020128544A1-20020912-P00008.png)
AU4910985A (US20020128544A1-20020912-P00008.png)
AU5558386A (US20020128544A1-20020912-P00008.png)
AU5344086A (US20020128544A1-20020912-P00008.png)
AU5537386A (US20020128544A1-20020912-P00008.png)
AU5597686A (US20020128544A1-20020912-P00008.png)
AU5130385A (US20020128544A1-20020912-P00008.png)